PrognomiQ Is Enabling Early Disease Detection And Treatment
PrognomiQ is a diagnostics company developing multi-omic blood tests for early detection and treatment of cancer and other complex diseases. By combining proprietary proteomics data at unprecedented scale with genomic and metabolomic data, the company builds transformative liquid biopsy products, including Provue Lung for early-stage lung cancer identification.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNov 2024
Mar 2022
Mar 2022
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
